Inventor
YAYON AVNER
IL32 patents
⚠️ This page may combine multiple inventors who share the name “YAYON AVNER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PROCHON BIOTECH LTD
11 patentsUS7009039B2Mar 7, 2006
Plasma protein matrices and methods for their preparation
PROCHON BIOTECH LTD1,418 citations97
US7563769B2Jul 21, 2009
FGF variants and methods for use thereof
PROCHON BIOTECH LTD54 citations96
US7288406B2Oct 30, 2007
Active variants of FGF with improved specificity
PROCHON BIOTECH LTD109 citations95
US7276481B2Oct 2, 2007
Method and composition for treatment of skeletal dysplasias
PROCHON BIOTECH LTD91 citations94
US7335508B2Feb 26, 2008
Porous plasma protein matrices and methods for preparation thereof
PROCHON BIOTECH LTD46 citations88
US7887831B2Feb 15, 2011
Bone enhancing composite
PROCHON BIOTECH LTD8 citations84
US8916522B2Dec 23, 2014
FGF-9 variants and methods of use thereof
PROCHON BIOTECH LTD4 citations82
US7714107B2May 11, 2010
Freeze-dried fibrin matrices and methods for preparation thereof
PROCHON BIOTECH LTD6 citations71
US9487568B2Nov 8, 2016
FGF-2 variants and methods of use thereof
PROCHON BIOTECH LTD0 citations51
US9862753B2Jan 9, 2018
FGF-2 variants having N-terminal deletions and increased receptor selectivity and methods of use thereof
PROCHON BIOTECH LTD0 citations48
US8940888B2Jan 27, 2015
Hydrazido derivatives of hyaluronic acid
PROCHON BIOTECH LTD0 citations47
YEDA RES & DEV
6 patentsUS6517872B1Feb 11, 2003
FGFR3 as a marker for mesenchymal skeletal progenitor cells
YEDA RES & DEV43 citations92
US5491220AFeb 13, 1996
Surface loop structural analogues of fibroblast growth factors
YEDA RES & DEV71 citations92
US6265632B1Jul 24, 2001
Animal model for fibroblast growth factor receptor associated chondrodysplasia
YEDA RES & DEV24 citations90
US6730666B1May 4, 2004
Pharmaceutical compositions comprising porphyrins and some novel porphyrin derivatives
YEDA RES & DEV15 citations79
US6447783B1Sep 10, 2002
Compositions comprising FGF9 and use thereof for stimulating cartilage and bone repair
YEDA RES & DEV12 citations74
US7264946B2Sep 4, 2007
Thermoanaerobacter brockii alcohol dehydrogenase promoter for expression of heterologous proteins
YEDA RES & DEV5 citations58
YAYON AVNER
6 patentsUS8962556B2Feb 24, 2015
FGF-2 variants having N-terminal deletions and increased receptor selectivity and uses thereof
YAYON AVNER15 citations88
US8101721B2Jan 24, 2012
Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof
YAYON AVNER14 citations83
US8828385B2Sep 9, 2014
Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
YAYON AVNER9 citations82
US8193317B2Jun 5, 2012
Freeze-dried fibrin matrices and methods for preparation thereof
YAYON AVNER7 citations81
US8618258B2Dec 31, 2013
Freeze-dried fibrin matrices and methods for preparation thereof
YAYON AVNER4 citations60
US8298528B2Oct 30, 2012
Methods for bone regeneration using endothelial progenitor cell preparations
YAYON AVNER0 citations40
CHILDRENS MEDICAL CENTER
2 patentsUS5789182AAug 4, 1998
System for assaying binding to a heparin-binding growth factor receptor
CHILDRENS MEDICAL CENTER33 citations92
US5270197ADec 14, 1993
Cells expressing a substantial number of surface high affinity HBGF receptors but relatively few low affinity HBGF binding sites and system for assaying binding to HBGF receptor
CHILDRENS MEDICAL CENTER11 citations73